Buy Like Buffett
Watchlist

Flagship explainer

How Fortress Biotech, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$61.2M · 100%Cost of revenue$20.9M · 34%Gross profit$40.3M · 66%Operating income−$70.2M · −115%Income before tax−$33.5M · −55%Income tax−$620000 · −1%Net income$6.8M · 11%As of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$61.2M100%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-037874 · filed Mar 31, 2026
Cost of revenue$20.9M34%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-037874 · filed Mar 31, 2026
$40.3M66%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-037874 · filed Mar 31, 2026
−$70.2M−115%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-037874 · filed Mar 31, 2026
Income before tax−$33.5M−55%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-037874 · filed Mar 31, 2026
Income tax−$620000−1%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-037874 · filed Mar 31, 2026
$6.8M11%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-037874 · filed Mar 31, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-037874 · filed Mar 31, 2026
· event Dec 31, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full Fortress Biotech, Inc. analysis at Buy Like Buffett